FindTrial
Sign In

Effects of anti-inflamation and lipid-lowering drugs in patients with cerebral aneurysms (ALLIANCE)

Effects of anti-inflamation and lipid-lowering drugs in patients with cerebral aneurysms (ALLIANCE)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100044255
Enrollment
Unknown
Registered
2021-03-12
Start date
2021-03-01
Completion date
Unknown
Last updated
2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

intracranial aneurysm

Interventions

Aspirin group:Taking aspirin
Aspirin combined with clopidogrel group: Taking aspirin and clopidogrel
No medication group:No medication
Lipid-lowering drug group:Taking statins
Aspirin combined with statins group:Taking aspirin and statins at the same time

Sponsors

Beijing Tiantan Hospital,Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Patients with unruptured intracranial aneurysms; 2. Aneurysm size >= 2mm; 3. Aged 18 to 75 years.

Exclusion criteria

Exclusion criteria: Patients with aneurysms associated with arteriovenous malformations or fistulas, dissecting, fusiform, and blood bubble like aneurysms.

Design outcomes

Primary

MeasureTime frame
High;Width;Neck width;Maximum size;Aspect ratio;Size ratio;Aneurysm wall enhancement grade;CRstalk;Signal Intensity;Aneurysm enhancement index (AEI);Aneurysm enhancement ratio (AER);—

Countries

China

Contacts

Public ContactAihua Liu

Beijing Tiantan Hospital

15901398688@163.comebeijingsh+86 15901398688

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026